2019
First commercial batch of FMD vaccine is manufactured in the new plant.
First commercial batch of FMD vaccine is manufactured in the new plant.
Already entering the pre-service stage, livestock fields have the possibility of preventing the appearance of diseases at a critical stage to ensure the results of the coming months.
In charge of the Commercial Management of CDV Laboratory, Fernando Matticoli reviews the current situation of a company that invests in the professionalization of its areas and plans its technical and commercial actions.
An immense joy invaded the almost 180 people who work day by day at the CDV Laboratory when the Senasa approved the new FMD vaccine that is elaborated in the productive unit that the company enabled towards the end of 2017.
The Republic of Argentina, due to the work carried out with the implementation of the strategies defined in the National Plan for the Eradication of FMD, has achieved the recognition of the OIE as "free of FMD".
Campylobacter and Trichomoniasis are diseases that are still present in about 20% of the establishments in the country. Their sole presence affects the productive yield of the entire establishment.
FMD vaccine production starts.
Authorization by SENASA for Plant 2 named FMD.
The construction of Plant 2 for FMD vaccine production starts with an investment of USD 40m.
Outsourcing productions are expanded to national and international laboratories.